SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-08-004196
Filing Date
2008-04-16
Accepted
2008-04-16 10:29:28
Documents
8
Period of Report
2008-05-13
Effectiveness Date
2008-04-16

Document Format Files

Seq Description Document Type Size
1 NOTICE OF ANNUAL MEETING y54002dpdef14a.htm DEF 14A 540585
2 GRAPHIC y54002dpy5400201.gif GRAPHIC 2705
3 GRAPHIC y54002dpy5400202.gif GRAPHIC 3528
4 GRAPHIC y54002dpy5400203.gif GRAPHIC 5205
5 GRAPHIC y54002dpy5400204.gif GRAPHIC 11076
6 GRAPHIC y54002dpy5400211.jpg GRAPHIC 162684
7 GRAPHIC y54002dpy5400213.jpg GRAPHIC 243851
8 GRAPHIC y54002dpy5400212.jpg GRAPHIC 356711
  Complete submission text file 0000950123-08-004196.txt   1625817
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15313 | Film No.: 08759004
SIC: 2833 Medicinal Chemicals & Botanical Products